Evaluation of immunological status in tumor-bearing dogs-Reference-Cited by-同舟云学术

Evaluation of immunological status in tumor-bearing dogs

Published:2009-12 Issue:2-4 Volume:132 Page:85-90
ISSN:0165-2427
Container-title:Veterinary Immunology and Immunopathology
language:en
Short-container-title:Veterinary Immunology and Immunopathology

Author:

Itoh Hiroshi,Horiuchi Yutaka,Nagasaki Teppei,Sakonju Iwao,Kakuta Tomoko,Fukushima Ushio,Uchide Tsuyoshi,Yamashita Mariko,Kuwabara Masato,Yusa Sei-ichi,Takase Katsuaki

Publisher

Elsevier BV

Subject

General Veterinary,Immunology

Reference35 articles.

1. The significance of an increase in soluble interleukin-2 receptor level in colorectal cancer and its biological regulating role in the physiological switching of the immune response cytokine network from TH1 to TH2 and back;Berghella;Cancer Immnunol. Immunother.,1998

2. Serum interleukin-10 in non-Hodgkin's lymphoma: a prognostic factor;Blay;Blood,1993

3. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma;Blay;Tumor Res.,1992

4. Transforming growth factor β and cyclosporine A inhibit the inducible activity of the interleukin-2 gene in T cells through a noncanonical octamer-binding site;Brabletz;Mol. Cell Biol.,1993

5. Variation in age at death of different sexes and breeds;Bronson;Am. J. Vet. Res.,1982

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A különböző immunológiai alapú terápiák alkalmazása a daganatok elleni küzdelemben : Irodalmi összefoglaló;Magyar Állatorvosok Lapja;2024

2. Cancer Immunotherapy;Veterinary Clinics of North America: Small Animal Practice;2023-12

3. Effects of Para-Toluenesulfonamide on Canine Melanoma Xenotransplants in a BALB/c Nude Mouse Model;Animals;2022-09-02

4. Association of Systemic Inflammatory and Immune Indices With Survival in Canine Patients With Oral Melanoma, Treated With Experimental Immunotherapy Alone or Experimental Immunotherapy Plus Metronomic Chemotherapy;Frontiers in Veterinary Science;2022-07-06

5. Canine Transforming Growth Factor-β Receptor 2-Ig: A Potential Candidate Biologic for Melanoma Treatment That Reverses Transforming Growth Factor-β1 Immunosuppression;Frontiers in Veterinary Science;2021-06-14